Caxton Associates (UK)’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$957K Buy
7,090
+1,852
+35% +$327K 0.02% 417
2026
Q1
$940K Buy
5,238
+1,867
+55% +$319K 0.02% 390
2025
Q4
$477K Buy
+3,371
New +$383K 0.01% 513

Other funds holding ALB

Caxton Associates (UK)'s ALB Position: Q2 2026 in Review

Caxton Associates (UK) increased its Albemarle (ALB) stake by 35% in Q2 2026, buying an estimated $327K and bringing the position to 7,090 shares worth $957K. The position accounts for 0.02% of the portfolio, ranked #417.

Caxton Associates (UK) first reported a position in ALB in Q4 2025 and has held it in 3 quarters since. 942 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Caxton Associates (UK) held 7,090 shares of Albemarle worth $957K as of Q2 2026.
  • Caxton Associates (UK) bought 1,852 Albemarle shares in Q2 2026, an estimated $327K.
  • Albemarle made up 0.02% of Caxton Associates (UK)'s portfolio in Q2 2026, its #417 holding.
  • Caxton Associates (UK) first reported a position in Albemarle in Q4 2025 and has held it in 3 quarters since.
  • 942 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.